Wall Street Brief: Paramount closes its Warner Bros merger, Schneider's $22.6B PTC takeover, and a $350M Amex AML penalty
A source-linked scan of the September 25–October 2 window's successor week, October 2–9, 2026: Paramount Skydance's completed $110 billion Warner Bros. Discovery acquisition, Schneider Electric's $22.6 billion all-cash takeover of PTC, two biotech Nasdaq pricings, CD&R and McKesson's $5.8 billion Option Care Health buyout, a $350 million OCC and Fed AML penalty against American Express, and the CFTC's crypto rulemaking notice.
Coverage window: Friday, October 2, to Friday, October 9, 2026.
Paramount Skydance completed its purchase of Warner Bros. Discovery on Tuesday, October 6, ending a contest that ran for more than a year. 1
Warner Bros. Discovery shareholders received $31.01666668 a share in cash, and the stock stopped trading on Nasdaq the same day. 1 The combined company is now called Skydance, and its Class B shares trade on the New York Stock Exchange under the ticker SKYD. 1
Reporting on the deal puts enterprise value near $110 billion and equity value near $81 billion. 23 Competition authorities in nearly 70 jurisdictions approved it, and Supreme Court Justice Elena Kagan declined a last-minute application to block the close. 4
Schneider Electric agreed two days earlier to buy the industrial software maker PTC for $205.00 a share in cash. 5 That values PTC's equity at about $22.6 billion, or €20.1 billion, and the enterprise at $23.7 billion, a 42.3% premium to PTC's last close. 5
Schneider will finance roughly €22 billion through a bridge facility from Morgan Stanley and Société Générale. 5 It expects to replace that bridge with €5–6 billion of equity and €16–17 billion of new debt, and to close by the third quarter of 2027. 5
Both deals were priced into a bond market that kept getting more expensive. The 10-year Treasury yield reached a 24-year high during the week, and the $39 billion 10-year and $22 billion 30-year auctions that followed drew solid demand. 6 The 10-year finished near 5.29% and the 30-year near 5.67%. 7 US high-yield yields stood at 8.2% on October 7, in the 54th percentile since 1994. 8
Minutes of the September 15–16 Federal Open Market Committee meeting, released October 7, said most participants judged that another increase in the target range would likely be appropriate by the end of the year. 9 Several described the current 3.75%–4.00% range as only mildly restrictive, and a couple raised their estimate of the neutral rate. 9
Regulators supplied the week's second concentration of news. The OCC fined American Express National Bank $350 million and ordered it to rebuild its Bank Secrecy Act and anti-money laundering program, saying the bank failed to report roughly $13 billion of suspected trade-based money laundering over the past decade. 10 The Federal Reserve issued a parallel order against American Express Company and American Express Travel Related Services, with corrective plans due within 90 days. 11
The SEC proposed widening the Investment Company Act's cross-trading rule so registered funds can again cross trade most fixed-income securities. 12 The CFTC published an advance notice of proposed rulemaking on crypto asset transactions and floated a dedicated "crypto asset market" category of exchange registration. 13
Bulge-bracket third-quarter results sit just outside this window. JPMorgan, Goldman Sachs, Citigroup and Wells Fargo report on October 13, and Morgan Stanley and Bank of America on October 14. 14
Two biotech companies priced Nasdaq offerings on October 8. TRex Bio raised $116.7 million at $14.00 a share, the bottom of its range, and Retension Pharmaceuticals raised an upsized $45 million at $12.00, the midpoint of its range. 1516
At a glance
| Area | Event | Stage and scale | Parties and advisers | Immediate read-through |
|---|---|---|---|---|
| IPOs and listings | TRex Bio (Nasdaq: TRXB) prices | Priced Oct 8; 8.33m shares at $14.00; $116.7m gross | J.P. Morgan, Evercore ISI, Cantor, Stifel lead; Wedbush PacGrow | Priced at the floor of a $14–16 range; first session closed level with the offer 15 |
| IPOs and listings | Retension Pharmaceuticals (Nasdaq: RTSN) prices | Priced Oct 8; 3.75m shares at $12.00; $45m, upsized | Leerink Partners, Guggenheim | Traded at $10.53 after its first session, 12.3% under the offer 16 |
| IPOs and listings | Pipeline concentrates in biotech | Two on the following week's calendar | City Therapeutics targets $175m at a $1.0bn valuation | Equity capital stays open for clinical-stage issuers 17 |
| M&A | Paramount Skydance completes Warner Bros. Discovery purchase | Closed Oct 6; ~$110bn enterprise, ~$81bn equity | Centerview, RedBird Advisors, BofA, Citi, M. Klein, LionTree; Allen & Company, J.P. Morgan, Evercore on the other side | WBD holders took $31.01666668 a share in cash; the merged company is Skydance (NYSE: SKYD) 1 |
| M&A | Schneider Electric to acquire PTC | Signed Oct 5; $205.00 a share, ~$22.6bn equity, $23.7bn enterprise | Bridge from Morgan Stanley and Société Générale | Schneider's largest deal on record; closing targeted for Q3 2027 5 |
| M&A | CD&R and McKesson to acquire Option Care Health | Signed Oct 6; ~$5.8bn including debt; $32.05 a share | CD&R 51%, McKesson ~49% for ~$1.4bn | A 37% premium to the October 5 close; close targeted for the first half of 2027 18 |
| M&A | Shionogi to acquire IntraBio | Signed Oct 5; $2.0bn upfront | Shionogi Inc., the US subsidiary | Adds Aqneursa (levacetylleucine) to the rare-disease portfolio 19 |
| Regulation | OCC and Fed enforcement against American Express | Orders Oct 8; $350m civil money penalty | OCC News Release 2026-87; Fed cease-and-desist order | Roughly $13bn of suspected trade-based money laundering went unreported over a decade 10 |
| Regulation | SEC cross-trading proposal | Proposed Oct 9; Rule 17a-7 amendments; 60-day comment | SEC Chairman Paul S. Atkins; file IC-36358 | Would restore cross trading of most fixed-income securities 12 |
| Regulation | SEC moves for final judgment against Ken Leech | Motion filed Oct 6; $3m penalty plus officer-and-director and associational bars | SEC v. Stephen Kenneth Leech II; Western Asset paid $100m in June | $103m in total goes back to harmed investors if the court approves 20 |
| Regulation | CFTC opens crypto rulemaking | Published Oct 5; 60-day comment | CFTC Chairman Michael S. Selig | Would create a purpose-built "crypto asset market" class of designated contract market 13 |
| Earnings | Bulge-bracket Q3 season opens next week | Calendar confirmed; no results in this window | JPMorgan, Goldman Sachs, Citigroup, Wells Fargo on Oct 13; Morgan Stanley and BofA on Oct 14 | The rate backdrop and deal pipeline set the questions, not the answers 14 |
| Personnel | JPMorgan hires Rob Sweeney as a global chair of investment banking | Announced Oct 6 | JPMorgan Chase; Sweeney arrives from Sycamore Partners, previously Goldman Sachs | Consumer and retail coverage; part of a push that has added more than 1,000 bankers this year 21 |
| Personnel | World Bank Group appoints a chief financial officer | Announced Oct 8 | David Vaillant, from BNP Paribas; succeeds Anshula Kant | Vaillant ran finance, strategy and participations at BNP Paribas Asset Management 22 |
| Financings | Tencent weighs an offshore bond sale | Reported Oct 8; up to $5bn | Bloomberg, citing people familiar with the plans | Dollar and yuan notes could come as early as October 23 |
| Financings | Oratomic raises a Series B | Closed in the week to Oct 8; $475m at $5.4bn | Co-led by ARCH Venture Partners and others | Valuation up from $1.5bn three months earlier; total raised now $775m 24 |
| Financings | Capitolis raises a Series E | Announced Oct 6; $220m at about $1.9bn | $120m of equity led by Citi, plus debt | Funds the eSecLending acquisition 25 |
IPOs and listings
TRex Bio priced 8,333,334 shares at $14.00 on October 8, the bottom of its $14.00–$16.00 range. 15 The South San Francisco company raised about $116.7 million before fees and began trading on the Nasdaq Global Select Market on October 9. 15 J.P. Morgan, Evercore ISI, Cantor and Stifel led the offering, with Wedbush PacGrow as a book-running manager. 15
The underwriters hold a 30-day option on 1,250,000 more shares, and the offering settles on October 13. 15
Retension Pharmaceuticals sold 3,750,000 shares at $12.00, an upsized $45 million, and listed on the Nasdaq Capital Market under RTSN. 16 Leerink Partners and Guggenheim ran the book. 16 The shares traded at $10.53 after the first session, 12.3% below the offer price. 26
Biotech carried the pipeline as well. City Therapeutics is next on the calendar, seeking $175 million at a $1.0 billion valuation. 17
M&A
Paramount Skydance and Warner Bros. Discovery. The $31.01666668 per-share cash price was fixed, so the closing delivered no last-minute revision. 1 The merged company carries nearly $70 billion of revenue, more than 200 million streaming subscribers and a $6 billion-plus run-rate synergy target over three years. 1
The balance sheet behind that target is already built. The $52 billion financing priced in late September funded the cash consideration, and $47 billion of new Class B equity went to the Ellison family, RedBird Capital, Saudi Arabia's Public Investment Fund, L'IMAD, the Qatar Investment Authority and LionTree at $12.00 a share. 1 Bank of America, Citigroup and Apollo led the debt. 1
Departing Warner Bros. Discovery chief executive David Zaslav collects about $606 million under his exit package. 27
Schneider Electric and PTC. Schneider's all-cash offer is the largest acquisition in its history and its second software move of the year, after a $3.1 billion agreement for Cognite. 28 PTC generated €2.4 billion of revenue in calendar 2025 at roughly a 40% adjusted EBITA margin, and the deal values it at 21 times forecast 2027 adjusted EBITA. 5
Schneider expects €250 million of cost synergies by the third year and about €800 million of revenue synergies from cross-selling. 5 The deal needs a majority vote of PTC shareholders and regulatory clearances, and Schneider has moved its own third-quarter revenue release forward to October 16. 5
CD&R and McKesson bid for Option Care Health. The $32.05 per-share cash offer values the home-infusion provider at about $5.8 billion including debt, a 37% premium to its October 5 close. 18 CD&R takes about 51% and McKesson invests roughly $1.4 billion for about 49%, keeping Option Care under its existing management team. 29
The companies expect to close in the first half of 2027. 29
Shionogi and IntraBio. Shionogi agreed to pay $2.0 billion upfront for IntraBio, a Texas biopharmaceutical company, through its US subsidiary. 19 The prize is Aqneursa, or levacetylleucine, approved in the United States and Europe for the neurological symptoms of Niemann-Pick disease type C. 30
Regulatory and enforcement
American Express: $350 million and a remediation order. The OCC's cease-and-desist order against American Express National Bank found staffing without sufficient expertise, gaps in internal controls and weak independent testing. 10 The bank had tailored its risk assessment to its narrow deposit products and underweighted its dominant card business. 10
The penalty goes to the US Treasury. 10 The Federal Reserve's concurrent order covers the holding company and the travel-related services unit, and requires corrective action plans within 90 days. 11
SEC: wider cross-trading for registered funds. Rule 17a-7 has let registered funds and their affiliates trade with each other since 1966, but the 2020 fund valuation rule cut that back for most fixed-income securities. 12 The proposal would restore that ground and add conditions on pricing and oversight, plus aggregated reporting of cross trades. 12 Comment runs 60 days from Federal Register publication. 12
SEC: the Leech cherry-picking case closes. Stephen Kenneth Leech II, former co-chief investment officer of Western Asset Management, consented to a $3 million penalty, an officer-and-director bar and a permanent injunction. 20 The SEC alleged that from January 2021 to October 2023 he delayed allocating trades until futures settlement prices were set, then sent first-day gains to favoured portfolios and losses to disfavoured ones. 20
Western Asset paid a $100 million penalty in June 2026, so court approval of Leech's judgment would return $103 million to investors. 20 Leech separately pleaded guilty to obstruction in June and awaits sentencing. 20
CFTC: a crypto rulemaking and a perpetual-futures reprieve. The advance notice of proposed rulemaking covers retail commodity transactions in crypto assets under section 2(c)(2)(D) of the Commodity Exchange Act. 13 Chairman Michael S. Selig framed it as building rules that prevent fraud rather than prosecuting it after the fact. 13 Comments are due 60 days after Federal Register publication. 13
Separately, the CFTC's Division of Market Oversight issued no-action relief letting exchanges strip expiration dates from existing perpetual-style broad-based security index futures. 31 The conditions include polling holders, giving advance notice and an exit window, and risk disclosures; the relief expires October 20. 31
The enforcement side has moved the other way. The CFTC brought 13 enforcement actions in 2025, against 58 in 2024 and nearly 100 in 2023, as crypto and prediction markets grew. 32 Senator Elizabeth Warren asked the Government Accountability Office on October 8 to examine the agency's staffing cuts. 33
Bulge-bracket earnings
The third-quarter reporting season begins on October 13, when JPMorgan, Goldman Sachs, Citigroup and Wells Fargo publish results. 14 Morgan Stanley and Bank of America follow on October 14. 14 JPMorgan has confirmed an 8:30 a.m. ET call on October 13, and Goldman Sachs has the same date on its investor calendar. 3435
What this window carries is the setup. Investors head into the season watching how a 10-year yield near 5.3% affects net interest income and marks, and whether the deal pipeline behind this week's transactions lifts advisory fees. 14 Revenue, segment results and guidance become available on October 13 and 14, and this brief will carry them in its next issue.
Leadership and personnel
JPMorgan Chase named Rob Sweeney, most recently of Sycamore Partners and before that Goldman Sachs, a global chair of investment banking. 21 He will advise large corporate clients with a focus on consumer and retail, working alongside senior bankers on key relationships. 21 The hire lands in a year when the bank has added more than 1,000 bankers. 21
The World Bank Group appointed David Vaillant as managing director and chief financial officer, replacing Anshula Kant, who had held the role since 2019. 22 Vaillant spent two decades at BNP Paribas, most recently as global head of finance, strategy and participations at BNP Paribas Asset Management. 22
Fifth Third Bancorp named Darren King head of its commercial bank, a unit that now includes regional banking; King had run it on an interim basis since June. 36 He had joined the bank in 2025 to lead regional banking and wealth management, after 24 years at M&T Bank. 36
Federal Reserve Financial Services appointed Kim Robbins chief payments executive, effective November 16, succeeding Mark Gould. 37
Skydance set its board: David Ellison as chairman, Ynon Kreiz as a director alongside his co-chief-executive role, and Laurene Powell Jobs and Bobby Kotick as independent directors. 38 Former UK prime minister Tony Blair joins as an adviser. 38
Mega financings and capital markets
Tencent is considering an offshore bond sale of up to $5 billion to fund artificial intelligence spending. 23 Dollar and yuan notes could come as early as this month. 39 The sale remains at the reported stage, so its coupon and final size are still open. 23
Oratomic, a Pasadena quantum computing startup founded in 2025, raised $475 million in a Series B led by ARCH Venture Partners and others. 24 The round values the company at $5.4 billion, up from $1.5 billion three months earlier, and brings total funding to $775 million. 40
Capitolis, which builds technology for banks to net and finance their trading exposures, raised $220 million, including $120 million of equity led by Citi and additional debt. 25 The round values it at about $1.9 billion, up from $1.6 billion in 2022, and funds its acquisition of eSecLending. 25
In the loan market, Mercer Advisors refinanced $1.9 billion of debt through a broadly syndicated loan and added a $340 million revolving credit facility. 41
Atlas Atomics, a nuclear startup backed by Vivek Ramaswamy, raised capital at a valuation of about $1.9 billion. 42
What to carry into next week
- October 13. JPMorgan, Goldman Sachs, Citigroup and Wells Fargo report third-quarter results; watch net interest income against a 10-year yield near 5.3% and advisory fees against the deal pipeline. 14
- October 13. TRex Bio's offering settles, and its 1,250,000-share overallotment determines final proceeds.
- October 14. Morgan Stanley and Bank of America report. 14
- October 16. Schneider Electric brings forward its third-quarter revenue release because of the PTC transaction. 5
- October 20. The CFTC's no-action relief on converting perpetual-style index futures into true perpetual futures expires. 31
- Coming weeks. Watch for Schneider's accelerator bookbuild for €5–6 billion of equity and its €16–17 billion debt issue, the PTC shareholder vote, and the first half of 2027 for the Option Care Health close. 529
- Comment clocks. The SEC's cross-trading proposal and the CFTC's crypto advance notice each run 60 days from Federal Register publication. 1213
- This month. Tencent's reported offshore bond sale could price as early as October; the coupon will be the read on demand for Chinese technology credit at current dollar rates. 39
References
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8Janus Henderson, "Could 8 be a lucky number in US high yield bonds?"
janushenderson.com
- 9
- 10OCC, News Release 2026-87
occ.gov
- 11
- 12
- 13CFTC, Release 9307-26
cftc.gov
- 14
- 15
- 16
- 17Renaissance Capital, "US IPO Week Ahead"
renaissancecapital.com
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26Renaissance Capital, IPO Center
renaissancecapital.com
- 27
- 28
- 29
- 30
- 31CFTC, Release 9308-26
cftc.gov
- 32
- 33
- 34
- 35Goldman Sachs, Investor relations
goldmansachs.com
- 36
- 37
- 38
- 39
- 40
- 41
- 42
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.